A federal judge upheld the validity of a key U.S. patent for Eli Lilly's blockbuster lung-cancer drug Alimta, a legal victory that could relieve sales pressure for the drug maker.
from WSJ.com: US Business http://ift.tt/1dMcUeT
via IFTTT
from WSJ.com: US Business http://ift.tt/1dMcUeT
via IFTTT
No comments:
Post a Comment